---
title: "J&J Receives U.S. FDA 510(K) Clearance For Monarch Quest 3"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/296106847.md"
datetime: "2026-08-17T12:33:17.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/296106847.md)
  - [en](https://longbridge.com/en/news/296106847.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/296106847.md)
generator: "portal-rs"
---

# J&J Receives U.S. FDA 510(K) Clearance For Monarch Quest 3

Aug 17 (Reuters) - Johnson & Johnson (JNJ.N) : \* JOHNSON & JOHNSON ANNOUNCES MONARCH™ QUEST 3, ADVANCING THE LATEST IN ROBOTICALLY-ASSISTED BRONCHOSCOPY Further company coverage: (JNJ.N)

### Related Stocks

- [JNJ.US](https://longbridge.com/en/quote/JNJ.US.md)

## Related News & Research

- [Johnson & Johnson Rises 1.3% as Investors Seek Stability](https://longbridge.com/en/news/296822154.md)
- [Johnson & Johnson $JNJ Position Reduced by Oppenheimer Asset Management Inc.](https://longbridge.com/en/news/296697035.md)
- [4,247 Shares in Johnson & Johnson $JNJ Bought by Xcel Wealth Management LLC](https://longbridge.com/en/news/296680207.md)
- [Commerce Bank Makes New Investment in Quest Diagnostics Incorporated $DGX](https://longbridge.com/en/news/296754573.md)
- [Commerzbank Aktiengesellschaft FI Takes $1.42 Million Position in Quest Diagnostics Incorporated $DGX](https://longbridge.com/en/news/296322041.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**